Northwestern Mutual Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.9K | Hold |
6,127
| – | – | ﹤0.01% | 2221 |
|
|
2025
Q1 | $46K | Sell |
6,127
-2,740
| -31% | -$20.6K | ﹤0.01% | 2205 |
|
|
2024
Q4 | $66.7K | Buy |
8,867
+8,340
| +1,583% | +$62.7K | ﹤0.01% | 2068 |
|
|
2024
Q3 | $4.01K | Buy |
+527
| New | +$4.01K | ﹤0.01% | 2961 |
|
|
2022
Q3 | – | Sell |
-1,453
| Closed | -$15K | – | 3118 |
|
|
2022
Q2 | $15K | Buy |
+1,453
| New | +$15K | ﹤0.01% | 2365 |
|
|
2021
Q2 | – | Sell |
-1,267
| Closed | -$13K | – | 2999 |
|
|
2021
Q1 | $13K | Buy |
+1,267
| New | +$13K | ﹤0.01% | 2204 |
|